Isoproterenol: Difference between revisions

No edit summary
No edit summary
Line 14: Line 14:


==Special Populations==
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C
*[[Lactation risk categories|Lactation risk]]:
*[[Lactation risk categories|Lactation risk]]: Unknown
*Renal Dosing
*Renal Dosing - undefined
**Adult
*Hepatic Dosing - undefined
**Pediatric
*Hepatic Dosing
**Adult
**Pediatric


==Indications==
==Indications==

Revision as of 21:09, 5 August 2016

General

Adult Dosing

  • Loading dose: 0.02-0.06 mg IV, followed by infusion[1][2]
    • 2-20 mcg/min IV infusion
    • Titrate to HR and BP

Pediatric Dosing

  • No well controlled studies for appropriate dosing
  • AHA recommends initial infusion of 0.1 mcg/kg/min, with titrated range usually 0.1-1 mcg/kg/min[3]

Special Populations

Indications

  • Refractory torsades
  • Refractory symptomatic bradycardia

Contraindications

  • Allergy to class/drug

Adverse Reactions

  • Dramatic increase in O2 demand
  • V-tach (use lowest dose possible)

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:

Kinetics

  • Onset of action = 1-5min
  • Duration of action = 1-2hr

Comments

See Also

References

  1. GlobalRPH. Isoproterenol Dilution. http://www.globalrph.com/isoproterenol_dilution.htm.
  2. AthenaHealth. Epocrates. Isoproterenol - Entire Monograph. https://online.epocrates.com/u/10a106/isoproterenol.
  3. GlobalRPH. Isoproterenol Dilution. http://www.globalrph.com/isoproterenol_dilution.htm.